1. Korea Centers for Disease Control and Prevention (KCDC). Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect. 2015; 6:269–278.
2. Cho K, Yoo J. KERI Insight: Estimation of economic loss from the Korean outbreak of MERS-CoV. Seoul: KERI;2015.
3. Oh MD, Choe PG, Oh HS, Park WB, Lee SM, Park J, Lee SK, Song JS, Kim NJ. Middle East Respiratory Syndrome Coronavirus Superspreading Event Involving 81 Persons, Korea 2015. J Korean Med Sci. 2015; 30:1701–1705.
Article
4. Kim KM, Ki M, Cho SI, Sung M, Hong JK, Cheong HK, Kim JH, Lee SE, Lee C, Lee KJ, Park YS, Kim SW, Choi BY. Epidemiologic features of the first MERS outbreak in Korea: focus on Pyeongtaek St. Mary's Hospital. Epidemiol Health. 2015; 37:e2015041.
Article
5. Park SH, Kim YS, Jung Y, Choi SY, Cho NT, Jeong HW, Hoe JY, Yoon JH, Lee J, Cheon S, Shon KM. Outbreaks of Middle East Respiratory Syndrome in two hospitals initiated by a single patient in Daejeon, South Korea. Infect Chemother. 2016; 48:99–107.
Article
6. Virlogeux V, Park M, Wu JT, Cowling BJ. Association between Severity of MERS-CoV Infection and Incubation Period. Emerg Infect Dis. 2016; 22:526–528.
Article
7. Min CK, Cheon S, Ha NY, Sohn KM, Kim Y, Aigerim A, Shin HM, Choi JY, Inn KS, Kim JH, Moon JY, Choi MS, Cho NH, Kim YS. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep. 2016; 6:25359.
Article
8. Perlman S, Dandekar AA. Immunopathogenesis of coronavirus infections: implications for SARS. Nat Rev Immunol. 2005; 5:917–927.
Article
9. Ng DL, Al Hosani F, Keating MK, Gerber SI, Jones TL, Metcalfe MG, Tong S, Tao Y, Alami NN, Haynes LM, Mutei MA, Abdel-Wareth L, Uyeki TM, Swerdlow DL, Barakat M, Zaki SR. Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East Respiratory Syndrome Coronavirus infection in the United Arab Emirates, April 2014. Am J Pathol. 2016; 186:652–658.
Article